RBR-946bv5
Active, Not Recruiting
N/A
Yellow Fever Vaccine immunity in patients using immunomodulatory therapies
Centro de Pesquisas René Rachou- FIOCRUZ0 sitesMay 18, 2018
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- nspecified rheumatoid arthritis
- Sponsor
- Centro de Pesquisas René Rachou- FIOCRUZ
- Status
- Active, Not Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Be over 18 years of age; to present a diagnosis of Rheumatoid Arthritis; being in use of immunosuppressants; be accompanied at the University Hospital of Brasília; have previously been vaccinated against yellow fever
Exclusion Criteria
- •Pregnant women ; organic mental illness; carriers of other autoimmune diseases or neoplasms
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not Yet Recruiting
N/A
Immunity induced by yellow fever vaccination in the elderly (60yrs or older)travellergele koorts, oudere, reizen, neutraliserende antistoffen, bijwerkingenyellow fever, elderly, travel, neutralizing antibodies, adverse eventsNL-OMON20831A.H.E. Roukens en L.G. Visser60
Active, Not Recruiting
N/A
Study of Yellow Fever Vaccine Administered With Sanofi Pasteur's Dengue Vaccine in Healthy Toddlers at 12-13 Months of Age in Colombia and PeruPrevention of symptomatic dengue diseaseTherapeutic area: Diseases [C] - Virus Diseases [C02]EUCTR2014-001714-26-Outside-EU/EEASanofi Pasteur SA792
Completed
N/A
Immunity after yellow fever vaccination in travelers using immunosuppressive medication-YETI studyYellow Fever infection10047438NL-OMON37037Academisch Medisch Centrum75
Completed
N/A
Immunity after yellow fever vaccination in HIV positive travelers - YELLAR studyYellow Fever Infection10047438NL-OMON39974Academisch Medisch Centrum60
Completed
N/A
ong-term immunity after Yellow fever vaccinatioYellow feverJPRN-UMIN000040526Tokyo Medical University Hospital Travellers' Medical Center50